Baidu
map

重症肌无力外科治疗京津冀专家共识

2020-04-30 天津医药.2020,48(4):327-332.

重症肌无力(MG)是乙酰胆碱受体抗体介导的、细胞免疫依赖和补体参与的神经肌肉接头(NMJ)处传递障碍的自身免疫性疾病。MG与胸腺病变密切相关,故除内科治疗外,胸腺切除术是治疗MG的一种重要方式。本文通

中文标题:

重症肌无力外科治疗京津冀专家共识

发布机构:

发布日期:

2020-04-30

简要介绍:

重症肌无力(MG)是乙酰胆碱受体抗体介导的、细胞免疫依赖和补体参与的神经肌肉接头(NMJ)处传递障碍的自身免疫性疾病。MG与胸腺病变密切相关,故除内科治疗外,胸腺切除术是治疗MG的一种重要方式。本文通过查阅国内外最新文献,汇集京津冀十余位本领域专家经验,针对MG的抗体分型、术前检查、手术指征、手术方式、术后治疗及随访写成专家共识,希望能指导MG的外科治疗。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=重症肌无力外科治疗京津冀专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bb41b1c001909998, title=重症肌无力外科治疗京津冀专家共识, enTitle=, guiderFrom=天津医药.2020,48(4):327-332., authorId=0, author=, summary=重症肌无力(MG)是乙酰胆碱受体抗体介导的、细胞免疫依赖和补体参与的神经肌肉接头(NMJ)处传递障碍的自身免疫性疾病。MG与胸腺病变密切相关,故除内科治疗外,胸腺切除术是治疗MG的一种重要方式。本文通, cover=https://img.medsci.cn/2020528/1590666737738_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Apr 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>重症肌无力(MG)是乙酰胆碱受体抗体介导的、细胞免疫依赖和补体参与的神经肌肉接头(NMJ)处传递障碍的自身免疫性疾病。MG与胸腺病变密切相关,故除内科治疗外,胸腺切除术是治疗MG的一种重要方式。本文通过查阅国内外最新文献,汇集京津冀十余位本领域专家经验,针对MG的抗体分型、术前检查、手术指征、手术方式、术后治疗及随访写成专家共识,希望能指导MG的外科治疗。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=10253, tagName=重症肌无力)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10253, guiderKeyword=重症肌无力, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2940, appHits=210, showAppHits=46, pcHits=616, showPcHits=2744, likes=0, shares=4, comments=13, approvalStatus=1, publishedTime=Thu May 28 22:13:02 CST 2020, publishedTimeString=2020-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu May 28 19:52:26 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 02:48:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=重症肌无力外科治疗京津冀专家共识.pdf)])
重症肌无力外科治疗京津冀专家共识.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1061702, encodeId=56be1061e02e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a45631090, createdName=ms5000002099118544, createdTime=Tue Oct 19 08:22:50 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954021, encodeId=43059540212c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5555342284, createdName=ms8000001360946332, createdTime=Mon Apr 05 20:38:04 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948703, encodeId=41c8948e0352, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a895447907, createdName=ms1000000914421005, createdTime=Tue Mar 16 15:13:59 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910530, encodeId=477c910530b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99252536671, createdName=1251209fm69暂无昵称, createdTime=Thu Dec 24 08:59:24 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895497, encodeId=5b9489549e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Thu Oct 29 20:32:25 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-10-19 ms5000002099118544

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1061702, encodeId=56be1061e02e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a45631090, createdName=ms5000002099118544, createdTime=Tue Oct 19 08:22:50 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954021, encodeId=43059540212c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5555342284, createdName=ms8000001360946332, createdTime=Mon Apr 05 20:38:04 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948703, encodeId=41c8948e0352, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a895447907, createdName=ms1000000914421005, createdTime=Tue Mar 16 15:13:59 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910530, encodeId=477c910530b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99252536671, createdName=1251209fm69暂无昵称, createdTime=Thu Dec 24 08:59:24 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895497, encodeId=5b9489549e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Thu Oct 29 20:32:25 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-04-05 ms8000001360946332

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1061702, encodeId=56be1061e02e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a45631090, createdName=ms5000002099118544, createdTime=Tue Oct 19 08:22:50 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954021, encodeId=43059540212c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5555342284, createdName=ms8000001360946332, createdTime=Mon Apr 05 20:38:04 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948703, encodeId=41c8948e0352, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a895447907, createdName=ms1000000914421005, createdTime=Tue Mar 16 15:13:59 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910530, encodeId=477c910530b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99252536671, createdName=1251209fm69暂无昵称, createdTime=Thu Dec 24 08:59:24 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895497, encodeId=5b9489549e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Thu Oct 29 20:32:25 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-03-16 ms1000000914421005

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1061702, encodeId=56be1061e02e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a45631090, createdName=ms5000002099118544, createdTime=Tue Oct 19 08:22:50 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954021, encodeId=43059540212c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5555342284, createdName=ms8000001360946332, createdTime=Mon Apr 05 20:38:04 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948703, encodeId=41c8948e0352, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a895447907, createdName=ms1000000914421005, createdTime=Tue Mar 16 15:13:59 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910530, encodeId=477c910530b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99252536671, createdName=1251209fm69暂无昵称, createdTime=Thu Dec 24 08:59:24 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895497, encodeId=5b9489549e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Thu Oct 29 20:32:25 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-12-24 1251209fm69暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1061702, encodeId=56be1061e02e1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a45631090, createdName=ms5000002099118544, createdTime=Tue Oct 19 08:22:50 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954021, encodeId=43059540212c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5555342284, createdName=ms8000001360946332, createdTime=Mon Apr 05 20:38:04 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948703, encodeId=41c8948e0352, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a895447907, createdName=ms1000000914421005, createdTime=Tue Mar 16 15:13:59 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910530, encodeId=477c910530b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99252536671, createdName=1251209fm69暂无昵称, createdTime=Thu Dec 24 08:59:24 CST 2020, time=2020-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895497, encodeId=5b9489549e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Thu Oct 29 20:32:25 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 124a6bfdm47暂无昵称

    学习

    0

拓展阅读

2011年中国重症肌无力诊断和治疗专家共识

中华医学会神经病学分会神经免疫学组 · 2011-09-01

2012 MGFA美国重症肌无力临床试验建议

美国重症肌无力基金会(MGFA,Myasthenia Gravis Foundation of America) · 2012-06-30

2014 EFNS/ENS眼肌型重症肌无力治疗指南

欧洲神经科学协会联盟(EFNS,European Federation of Neurological Societies) · 2014-01-28

中国重症肌无力诊断和治疗指南2015

中华医学会神经病学分会神经免疫学组 · 2016-04-25

2016 重症肌无力的管理国际共识指南(全文)

美国重症肌无力基金会(MGFA,Myasthenia Gravis Foundation of America) · 2016-06-29

2016 重症肌无力的管理国际共识指南(执行摘要)

美国重症肌无力基金会(MGFA,Myasthenia Gravis Foundation of America) · 2016-07-13

Baidu
map
Baidu
map
Baidu
map